Federal Act
on Medicinal Products and Medical Devices
(Therapeutic Products Act, TPA)

English is not an official language of the Swiss Confederation. This translation is provided for information purposes only and has no legal force.

of 15 December 2000 (Status as of 26 May 2021)


Open article in different language:  DE  |  FR  |  IT
Art. 9b Temporary authorisation for use and limited placing on the market 42

1 The Agency may tem­por­ar­ily au­thor­ise the use of medi­cin­al products re­ferred to in Art­icle 9 para­graph 2 let­ter d on cer­tain per­sons or on cer­tain cat­egor­ies of per­sons out­side clin­ic­al tri­als.

2 It may also au­thor­ise the tem­por­ary or quant­it­at­ive mar­ket­ing of a medi­cin­al product to bridge the tem­por­ary un­avail­ab­il­ity of an identic­al medi­cin­al product au­thor­ised in Switzer­land, provided that:

a.
the medi­cin­al product is au­thor­ised in an­oth­er coun­try that has equi­val­ent medi­cin­al product con­trol; and
b.
no es­sen­tially identic­al medi­cin­al product is au­thor­ised and avail­able in Switzer­land.

42 In­ser­ted by No I of the FA of 18 March 2016, in force since 1 Jan. 2019 (AS 2017 2745, 2018 3575; BBl 2013 1).

Previous article Show article in the law Next article

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback